Evidence map›Paper›PMID 34203988›Full record

ArticleInternational journal of molecular sciences2021

(S)-Reutericyclin: Susceptibility Testing and In Vivo Effect on Murine Fecal Microbiome and Volatile Organic Compounds.

Bernhard Kienesberger, Beate Obermüller, Georg Singer, Barbara Mittl, Reingard Grabherr, Sigrid Mayrhofer, Stefan Heinl, Vanessa Stadlbauer, Angela Horvath, Wolfram Miekisch and 4 more

Abstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in International journal of molecular sciences, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed.

  1. Article
  2. Article
  3. Probiotic OMNi-BiOTiCNutrients · 2023
    Article
  4. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

14 authors.

Bernhard KienesbergerDepartment of Paediatric and Adolescent Surgery, Medical University of Graz, 8036 Graz, Austria.
Beate ObermüllerDepartment of Paediatric and Adolescent Surgery, Medical University of Graz, 8036 Graz, Austria.
Georg SingerDepartment of Paediatric and Adolescent Surgery, Medical University of Graz, 8036 Graz, Austria.ORCID 0000-0003-4770-3144
Barbara MittlDepartment of Paediatric and Adolescent Surgery, Medical University of Graz, 8036 Graz, Austria.
Reingard GrabherrDepartment of Biotechnology, University of Natural Resources and Life Sciences Vienna, 1190 Vienna, Austria.ORCID 0000-0002-4501-927X
Sigrid MayrhoferDepartment of Biotechnology, University of Natural Resources and Life Sciences Vienna, 1190 Vienna, Austria.
Stefan HeinlDepartment of Biotechnology, University of Natural Resources and Life Sciences Vienna, 1190 Vienna, Austria.
Vanessa StadlbauerDepartment of Internal Medicine, Division of Gastroenterology and Hepatology, Medical University of Graz, 8036 Graz, Austria.ORCID 0000-0001-5508-8271
Angela HorvathDepartment of Internal Medicine, Division of Gastroenterology and Hepatology, Medical University of Graz, 8036 Graz, Austria.ORCID 0000-0001-7279-0628
Wolfram MiekischExperimental Research Center, Department of Anesthesiology and Intensive Care, Rostock University Medical Center, 18057 Rostock, Germany.ORCID 0000-0003-1619-0315
Patricia FuchsExperimental Research Center, Department of Anesthesiology and Intensive Care, Rostock University Medical Center, 18057 Rostock, Germany.ORCID 0000-0002-0055-6098
Ingeborg KlymiukGottfried Schatz Research Center, Department of Cell Biology, Histology and Embryology, Medical University of Graz, 8036 Graz, Austria.ORCID 0000-0001-8755-0037
Holger TillDepartment of Paediatric and Adolescent Surgery, Medical University of Graz, 8036 Graz, Austria.
Christoph CastellaniDepartment of Paediatric and Adolescent Surgery, Medical University of Graz, 8036 Graz, Austria.ORCID 0000-0002-4512-3640

Funding

Österreichische Forschungsförderungsgesellschaft 867991
6 · The paper itself

Abstract

We aimed to assess the in vitro antimicrobial activity and the in vivo effect on the murine fecal microbiome and volatile organic compound (VOC) profile of (S)-reutericyclin. The antimicrobial activity of (S)-reutericyclin was tested against

Indexed as

AnimalsDiscriminant AnalysisFecesMaleMiceMice, Inbred BALB CMicrobial Sensitivity TestsMicrobiotaTenuazonic AcidVolatile Organic CompoundsreutericyclinTenuazonic AcidVolatile Organic Compoundsantibioticantimicrobial activitybacteriocinisoformmicrobiomeresistancereutericyclinVOC

Identifiers

PMID34203988
PMCPMC8232739

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.